CHARLES WOOD: Open Payments
NPI 1356834766 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $97 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Novo Nordisk Inc | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: AIRSUPRA, JARDIANCE, FARXIGA, INSPIRE, UBRELVY, Symbravo, Wegovy.
Industry payments across MS — which companies pay providers there.
